Kingston General Hospital - Allergy Research

Kingston General Hospital - Allergy Research Allergy Research Division of Kingston Health Sciences Centre - KGH The EEU is recognized by the U.S.

This unique facility, conceived of and pioneered by Dr. James Day and Dr. Reginald Clark in the early 1980s, has been refined and developed over the past two decades garnering it recognition around the world and bringing to you an innovative new way to conduct allergy research trials. As a fully validated and GCP compliant research environment, the EEU has been used to evaluate the onset of action and efficacy of antihistamines, nasal corticosteroids and other investigational medications in the treatment of allergic rhinitis and resulted in studies undertaken by a majority of the multinational pharmaceutical companies involved with anti-allergic treatments. As a highly controlled indoor environment, the EEU eliminates the variables of weather, subject environment, and the changing antigenicity of seasonal ragweed so that studies can be conducted at any time of the year and subject responses to the allergen of interest can be readily evaluated. FDA and European Medicines Agency (EMEA) as a means to assess onset of action of anti-allergic treatment.

Address

76 Stuart Street
Kingston, ON
K7L 2V7

Website

Alerts

Be the first to know and let us send you an email when Kingston General Hospital - Allergy Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Kingston General Hospital - Allergy Research:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category